Seagen Inc.(NASDAQ : SGEN)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|LLY||Eli Lilly & Co.||1.08%||365.63||1.1%||$1192.52m|
|JNJ||Johnson & Johnson||0.12%||177.22||0.7%||$1097.25m|
|MRK||Merck & Co., Inc.||0.60%||107.46||0.7%||$994.87m|
|BMY||Bristol-Myers Squibb Co.||0.16%||79.27||1.1%||$751.13m|
|IDXX||IDEXX Laboratories, Inc.||-1.24%||411.36||3.9%||$222.64m|
|HZNP||Horizon Therapeutics Plc||0.97%||78.28||5.4%||$201.37m|
|ALNY||Alnylam Pharmaceuticals, Inc.||2.03%||212.72||8.0%||$159.13m|
|NVO||Novo Nordisk A/S||0.86%||118.84||0.1%||$155.62m|
Seagen Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997, and is headquartered in Bothell, WA.